Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2022-01-01
2022-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
SERUM MBPC LEVELS BETWEEN TWO GROUPS EVALUATED.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Protein and Ultrasound Indicators of Preterm Birth
NCT01412931
Proteomic Assessment of Preterm Birth
NCT01371019
Maternal Serum Markers Predicting Preeclampsia At Early Gestations
NCT05131282
Predictive Value of Maternal Blood Protein Signatures in Preterm Birth
NCT06664554
Glycoproteomic Analysis of Urine in Women Undergoing Spontaneous Preterm Delivery
NCT01348230
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
SERUM MBPC LEVELS BETWEEN TWO GROUPS EVALUATED.A TOTAL OF 90 WOMEN WERE PLANNED TO INCLUDE 45 STUDY 45 CONTROL GROUP IN THE STUDY.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
women who gave birth prematurely
women who had serum taken in the first trimester and gave birth earlier than 37 weeks according to the time of delivery
level of myosin binding protein c in serum
Serum samples will be taken from the participants in the first trimester, transferred to eppendorf tubes after appropriate procedures, and stored at -80 degrees until the time of deliveryParticipants will be divided into two groups according to the timing of birthThe first group is those who gave birth earlier than 37 weeks those who gave birth on time in the other group The mbpc levels will be looked at and compared.
those who gave birth on time
women who have had serum taken in the first trimester, stored and delivered on time
level of myosin binding protein c in serum
Serum samples will be taken from the participants in the first trimester, transferred to eppendorf tubes after appropriate procedures, and stored at -80 degrees until the time of deliveryParticipants will be divided into two groups according to the timing of birthThe first group is those who gave birth earlier than 37 weeks those who gave birth on time in the other group The mbpc levels will be looked at and compared.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
level of myosin binding protein c in serum
Serum samples will be taken from the participants in the first trimester, transferred to eppendorf tubes after appropriate procedures, and stored at -80 degrees until the time of deliveryParticipants will be divided into two groups according to the timing of birthThe first group is those who gave birth earlier than 37 weeks those who gave birth on time in the other group The mbpc levels will be looked at and compared.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* be between 18-40 years old
Exclusion Criteria
* being pregnant with assisted reproductive techniques
* having a multiple pregnancy
* have cervical insufficiency
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gaziosmanpasa Research and Education Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elif Yıldız
MEDİCAL DOCTOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
elif yıldız
Role: PRINCIPAL_INVESTIGATOR
Gaziosmanpasa Research and Education Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gaziosmanpasa Training and Research Hospital
Istanbul, Gaziosmanpaşa, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GaziosmanpasaTREHKHD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.